Cost-Effectiveness of Phenytoin and Levetiracetam for Seizure Prophylaxis in Traumatic Brain Injury

Date
2018-04-06
Authors
Young, Nicole
Tokumaru, Sheri
Taira, Deborah
Izumi, Kara
Stern, Tracy
Dittrich, Denise
Asai, Susan
Nakagawa, Kazuma
Contributor
Advisor
Department
Instructor
Tokumaru, Sheri
Taira, Deborah
Depositor
Speaker
Researcher
Consultant
Interviewer
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
Seizures are a potential complication associated with traumatic brain injury (TBI), which can lead to secondary brain injury and increased risk for developing post-traumatic epilepsy. Current guidelines recommend the use of antiepileptic drug (AED) for early seizure prophylaxis in patients with TBI. Both phenytoin (PHE) and levetiracetam (LEV) have become standard of practice for seizure prophylaxis in TBI, yet the cost effectiveness is not well studied.
Description
Poster
Keywords
Traumatic brain injury, Anticonvulsants, Seizure prophylaxis, Phenytoin, Levetiracetam, Cost effectiveness
Citation
Extent
1 poster
Format
Geographic Location
Time Period
Related To
Table of Contents
Rights
Open access
Rights Holder
Local Contexts
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.